Cargando…
T Cell Energy Metabolism Is a Target of Glucocorticoids in Mice, Healthy Humans, and MS Patients
Glucocorticoids (GCs) are used to treat inflammatory disorders such as multiple sclerosis (MS) by exerting prominent activities in T cells including apoptosis induction and suppression of cytokine production. However, little is known about their impact on energy metabolism, although it is widely acc...
Autores principales: | Meyer-Heemsoth, Leonie, Mitschke, Katja, Bier, Jasmina, Schütz, Konstantin, Villunger, Andreas, Legler, Tobias J., Weber, Martin S., Lühder, Fred, Reichardt, Holger M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914408/ https://www.ncbi.nlm.nih.gov/pubmed/36766792 http://dx.doi.org/10.3390/cells12030450 |
Ejemplares similares
-
Protection of Antigen-Primed Effector T Cells From Glucocorticoid-Induced Apoptosis in Cell Culture and in a Mouse Model of Multiple Sclerosis
por: Bier, Jasmina, et al.
Publicado: (2021) -
Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids
por: Lühder, Fred, et al.
Publicado: (2017) -
The Role of Glucocorticoids in Inflammatory Diseases
por: Reichardt, Sybille D., et al.
Publicado: (2021) -
Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells
por: Meers, Garrit K., et al.
Publicado: (2018) -
T-cell autonomous death induced by regeneration of inert glucocorticoid metabolites
por: Rocamora-Reverte, Lourdes, et al.
Publicado: (2017)